Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
Plus de filtres











Gamme d'année
1.
J Pharm Sci ; 112(5): 1305-1314, 2023 05.
Article de Anglais | MEDLINE | ID: mdl-36657719

RÉSUMÉ

N-nitrosamines (NA) impurities have unexpectedly been found in sartan products, angiotensin II receptor antagonists that are used to control hypertension, representing an urgent concern for industry, global regulators and for the patients. In this study, an HPLC-MS/MS method was developed and validated for the quantification of six NA (N-nitrosodimethylamine, N-Nitroso-N-methyl-4-aminobutyric acid, N-Nitrosodiethylamine, N-ethyl-N-nitroso-2-propanamine, N-nitroso-diisopropylamine and N-nitroso-di-n-butylamine) in losartan, valsartan, olmesartan, irbesartan, candesartan and telmisartan products. The method was validated in terms of sensitivity, linearity, accuracy, precision, robustness and stability. The limits of quantification were 100, 31.25, 250, 33, 312.5 and 125 µg kg-1 in losartan, valsartan, olmesartan, irbesartan, candesartan and telmisartan samples, respectively, which met the sensitivity requirements for the limits set by Food and Drug Administration of the United States. The standard curves showed good linearity. The recoveries ranged from 93.06 to 102.23% in losartan matrix, 83 to 85.9% in valsartan, 96.1 to 101.2% in olmesartan, 89.2 to 97.5% in irbesartan, 93.4 to 132.0% in candesartan and 62.3 to 106.2% in telmisartan matrix. The other parameters met the validation criteria, the good sensitivity and precision, high accuracy and simple and fast analysis provides a reliable method for quality control of NA in sartan pharmaceutical products. The developed method was successfully applied for the determination of N-nitrosamines in 71 sartan products marketed in Brazil.


Sujet(s)
Nitrosamines , Humains , Nitrosamines/analyse , Antagonistes du récepteur de type 1 de l'angiotensine-II , Chromatographie en phase liquide à haute performance , Spectrométrie de masse en tandem/méthodes , Losartan , Cancérogènes/analyse , Irbésartan/analyse , Préparations pharmaceutiques , Telmisartan , Brésil , Valsartan/analyse , Valsartan/composition chimique
2.
Sci Rep ; 12(1): 19050, 2022 11 09.
Article de Anglais | MEDLINE | ID: mdl-36351942

RÉSUMÉ

Antibiotic resistance genes (ARGs) are widespread in the environment due to the overuse of antibiotics and other pollutants, posing a threat to human and animal health. In this study, we evaluated antimicrobial residues, bacterial diversity and ARGs in two important watersheds, Guandu and São João, that supply drinking water to Rio de Janeiro city, Brazil. In addition, tap water samples were collected from three different cities in Rio de Janeiro State, including the metropolitan area of Rio de Janeiro city. Clarithromycin, sulfamethoxazole and azithromycin were found in untreated water and drinking water in all samples. A greater abundance of Proteobacteria was observed in Guandu and São João watersheds, with most of the sequences belonging to the Gammaproteobacteria class. A plasmidome-focused metagenomics approach revealed 4881 (Guandu), 3705 (São João) and 3385 (drinking water) ARGs mainly associated with efflux systems. The genes encoding metallo-ß-lactamase enzymes (blaAIM, blaGIM, blaIMP, and blaVIM) were detected in the two watersheds and in drinking water samples. Moreover, we demonstrated the presence of the colistin resistance genes mcr-3 and mcr-4 (both watersheds) and mcr-9 (drinking water and Guandu) for the first time in Brazil. Our data emphasize the importance of introducing measures to reduce the disposal of antibiotics and other pollutants capable of promoting the occurrence and spread of the microbial resistome on aquatic environments and predicting possible negative impacts on human health.


Sujet(s)
Eau de boisson , Polluants environnementaux , Microbiote , Animaux , Humains , Eau de boisson/microbiologie , Brésil , Antibactériens/pharmacologie , Gènes bactériens
3.
Vigil. sanit. debate ; 6(2): 18-28, maio 2018.
Article de Portugais | LILACS-Express | LILACS | ID: biblio-916409

RÉSUMÉ

Introdução: Efluentes hospitalares representam riscos à saúde pública e ambiental devido à presença de microrganismos patogênicos, drogas e produtos químicos. Pseudomonas aeruginosa é um patógeno oportunista frequentemente encontrado no ambiente hospitalar. Objetivo: Avaliar o resistoma de isolados de P. aeruginosa da estação de tratamento de esgoto hospitalar (ETEH) de um complexo hospitalar na cidade do Rio de Janeiro. Método: Vinte isolados dos cinco estágios da ETEH foram identificados como P. aeruginosa pelo sequenciamento do gene 16S rRNA. A suscetibilidade aos antibióticos foi determinada segundo o CLSI e os genes qacEΔ1 e sul1 foram detectados pela PCR. Resíduos de sulfonamidas foram pesquisados por cromatografia líquida de alta eficiência acoplada à espectrometria de massas sequencial. Resultados: Foi demonstrada a presença de sulfametoxazol em nível inferior a 50 ng∙L−1, resistência às sulfonamidas (80%) seguida pelas quinolonas (50%) e 13 perfis de suscetibilidade aos antimicrobianos. Os genes qacEΔ1-sul1 foram detectados em 100% dos isolados, sugerindo a presença de integrons de classe 1 em toda a ETEH. Conclusões: Os resultados sinalizaram limitações no tratamento e a propagação de genes de resistência nas etapas da ETEH. Esses dados contribuem com órgãos competentes no desenho de ações preventivas frente aos impactos negativos à saúde pública.


Introduction: Hospital effluents may pose great environmental risk due to the presence of pathogenic microorganisms, drugs and chemical components. Pseudomonas aeruginosa is an opportunistic pathogen frequently found in hospital environment. Objective: To evaluate the resistome of P. aeruginosa from the hospital wastewater treatment plant (HWTP) in a hospital complex of Rio de Janeiro city. Method: Twenty isolates from the five stages of the HWTP were identified as P. aeruginosa by 16S rRNA gene sequencing analysis. Susceptibility to antibiotics was determined according to CLSI and qacEΔ1 and sul1 genes were detected by PCR. Sulphonamide residues were investigated by high performance liquid chromatography coupled to sequential mass spectrometry. Results: The sulfamethoxazole has been demonstrated at a level below 50 ng L-1. Sulfonamide resistance (80%) has been demonstrated followed by quinolone class (50%) and 13 susceptibility patterns to antimicrobials. The qacEΔ1-sul1 genes were detected in 100% of isolates suggesting the presence of class 1 integrons in the whole HWTP. Conclusions: The results signalized limitations of HWTP and propagation of resistance genes in all stages of the HWTP. These data also contribute to the environmental sanitary surveillance in the design of prevention actions against negative impact on the public health.

4.
J Sep Sci ; 38(21): 3743-9, 2015 Nov.
Article de Anglais | MEDLINE | ID: mdl-26340418

RÉSUMÉ

A simple extraction technique has been developed for seven macrolide antibiotics in milk. The procedure involves a modified quick, easy, cheap, effective, rugged, and safe method based on acetonitrile extraction, followed by the addition of a mixture of salts (sodium sulfate, sodium chloride, and potassium carbonate) not yet reported in literature. The method was validated for tylosin and was selective, free of matrix effect, and linear in the range of 0.78-18.75 ng/mL in the final extract, corresponding to 0.125-3 times the maximum residue limit. The limit of detection, limit of quantification, decision limit, and detection capability were, respectively, 0.84, 2.79, 58.4, and 71.7 µg/kg. The overall average recovery at 25, 50, and 75 µg/kg ranged from 89-97%. Repeatability and intermediate precision expressed by relative standard deviations were below 10.5 and 12%, respectively. The extension of the validation for spiramycin, throleandomycin, oleandomycin, roxithromycin, erythromycin, and clarithromycin is under consideration since the procedure proved to be able to efficiently extract all studied macrolides, with recoveries from 74-104% at 50 µg/kg for tylosin, erythromycin, spiramycin, and oleandomycin and 20 µg/kg for throleandomycin, roxithromycin, and clarithromycin.


Sujet(s)
Chromatographie en phase liquide/méthodes , Macrolides/isolement et purification , Lait/composition chimique , Sels/composition chimique , Spectrométrie de masse en tandem/méthodes , Animaux , Limite de détection , Macrolides/analyse , Reproductibilité des résultats
5.
Anal Chim Acta ; 682(1-2): 82-92, 2010 Dec 03.
Article de Anglais | MEDLINE | ID: mdl-21056719

RÉSUMÉ

A liquid chromatography-electrospray ionization tandem mass spectrometric (LC-ESI-MS/MS) method was developed and validated for the determination of residues of 6 polyether ionophores (lasalocid, maduramicin, monensin, narasin, salinomycin, semduramicin), 3 macrolides (erythromycin, tylosin, clarithromycin) and 1 lincosamide (lincomycin) in eggs. Nigericin was used as qualitative internal standard. Samples were deproteinizated/extracted with acetonitrile without pH adjustments. Aliquots of the extracts were evaporated and reconstituted for injection in the instrument operated in positive multiple reaction monitoring (MRM) mode. The stability of the antibiotics and the intensity of the formed ions were considered in order to select a suitable solvent for the reconstitution of the obtained dry extracts. No clean-up steps were required and matrix effects were controlled by sample dilution, selection of appropriate chromatographic conditions and reduced injection volume. Good within-laboratory reproducibility was obtained, with relative standard deviations (RSD(R)) from 4.0 (semduramicin at 5 µgkg(-1)) to 18.6 (erythromycin at 25 µgkg(-1)) for the ionophores and macrolides. Lincomycin showed the least precise results, with a maximum RSD(R) of 20.2% at 75 µgkg(-1)). Satisfactory decision limits (CCα) and detection capabilities (CCß) were also attained. Method limits of detection (LODs) from 0.04 (salinomycin) to 1.6 µgkg(-1) (lincomycin) were achieved. Method limits of quantification (LOQs) were from 0.14 to 5.3 µgkg(-1) for the same drugs, respectively. All the LOQs, except that obtained for maduramicin were remarkably below the lowest validation level. The proposed method is suitable for routine application in commercial egg samples.


Sujet(s)
Antibactériens/analyse , Oeufs/analyse , Ionophores/analyse , Lincosamides/analyse , Macrolides/analyse , Spectrométrie de masse ESI/méthodes , Animaux , Calibrage , Poulets , Chromatographie en phase liquide/méthodes , Limite de détection , Reproductibilité des résultats
6.
Article de Anglais | MEDLINE | ID: mdl-24779620

RÉSUMÉ

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, which has recently been developed and validated, was used for the identification and quantification of polyether ionophore, macrolide and lincosamide residues in commercial eggs sold in the metropolitan area of Rio de Janeiro, Brazil. The method was applied to 100 samples and the results showed a high incidence of polyether ionophore residues (25%). Salinomycin was detected in 21% of samples, but only two non-compliant results (5.3 and 53 µg kg(-1)) were found if maximum limits (tolerances) established by European Union were adopted in Brazil and if a method decision limit (CCα) of 3.4 µg kg(-1) was considered. In 8% of analyzed samples, more than one studied coccidiostat was found. The lincosamide, lincomycin, and the macrolide, tylosin, were detected at trace levels in 4 and 1% of the samples, respectively. Lasalocid, clarithromycin and erythromycin were not found.


Sujet(s)
Oeufs/analyse , Éthers/analyse , Ionophores/analyse , Lincosamides/analyse , Macrolides/analyse , Résidus de pesticides/analyse , Animaux , Antibactériens/analyse , Brésil , Poulets , Chromatographie en phase liquide à haute performance , Chromatographie en phase liquide/méthodes , Coccidiostatiques/analyse , Union européenne , Contamination des aliments/analyse , Humains , Concentration maximale admissible , Spectrométrie de masse en tandem/méthodes
7.
Article de Anglais | MEDLINE | ID: mdl-24779621

RÉSUMÉ

This pilot survey aimed to assess the occurrence of tetracyclines and the 4-epimers of oxytetracycline, tetracycline and chlortetracycline in commercial pasteurized milks sold in the metropolitan area of Rio de Janeiro, Brazil, between October 2009 and March 2010. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, developed and validated in our laboratory, was used. All 100 analyzed samples were compliant, but 14 contained oxytetracycline in concentrations ranging from the method limit of detection (3.7 µg l(-1)) to the method limit of quantification (12.2 µg l(-1)). One sample contained oxytetracycline and tetracycline simultaneously (at a concentration slightly higher than method limit of quantification, 7.0 µg l(-1)). The presence of 4-epioxytetracycline and 4-epitetracycline in contaminated samples with the parent drugs could not be confirmed as traces were detected only in the quantification MRM transition. No other tetracyclines were detected.


Sujet(s)
Antibactériens/analyse , Chlortétracycline/analyse , Lait/composition chimique , Oxytétracycline/analyse , Tétracycline/analyse , Tétracyclines/analyse , Animaux , Brésil , Chromatographie en phase liquide/méthodes , Résidus de médicaments/analyse , Contamination des aliments/analyse , Humains , Pasteurisation , Spectrométrie de masse en tandem/méthodes
8.
Anal Chim Acta ; 656(1-2): 72-84, 2009 Dec 10.
Article de Anglais | MEDLINE | ID: mdl-19932817

RÉSUMÉ

A liquid chromatography-electrospray ionization tandem mass spectrometric (LC-ESI-MS/MS) method for the analysis of several tetracyclines residues in bovine milk has been developed. Milk deproteinization/extraction of samples was performed with acidified acetonitrile. After diluting and purification by solid-phase extraction (SPE), the extracts were injected into the instrument operated in Multiple Reaction Monitoring (MRM) acquisition mode. The reversible epimerization at C-4 of oxytetracycline, tetracycline and chlortetracycline and the keto-enol tautomerism of chlortetracycline between C-11a and C-12 were considered for reliable quantification. Degradation was also taken in account and minimized for the same purpose. A central composite (response surface) design with desirability function was employed for the optimization of extraction and clean-up steps. The optimization improved the extraction efficiency of the more polar analytes reaching 93.9% for 4-epioxytetracycline and 95.8% for oxytetracycline at 100 microg L(-1). The validation was performed following the criteria established by Commission Decision 2002/657/EC.


Sujet(s)
Chromatographie en phase liquide/méthodes , Lait/composition chimique , Spectrométrie de masse ESI/méthodes , Spectrométrie de masse en tandem/méthodes , Tétracyclines/analyse , Tétracyclines/composition chimique , Animaux , Conformation moléculaire , Extraction en phase solide , Stéréoisomérie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE